MicroStrategy (NasdaqGS:MSTR) is currently facing a legal battle with the announcement of a class action lawsuit by Pomerantz LLP, alleging misleading statements about its bitcoin-focused strategy.

Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

In 'Diet, Drugs, and Dopamine,' former FDA Commissioner David A. Kessler offers a comprehensive guide to weight loss.

As mentioned, strength training can help you burn more calories during and after your workout. This is thanks to the lean ...

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

If your veterinarian has advised that your dog needs to shed some pounds, here are some effective and sometimes surprising ways to help your canine companion achieve a healthier weight.

Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

Novo Nordisk's stock has plummeted over 60%, while also arguably losing market share to Eli Lilly. Click here to find out why ...

The market may extend its rally if it decisively clears the previous week’s high in the upcoming sessions. Below are some ...

In 2013, fans started to notice her weight loss transformation, but she didn’t want people to think she had turned to easy fixes like plastic surgery. “I lost my weight the healthy and good ...

One more important factor for weight loss: GLP-1 drugs like semaglutide can activate GLP-1 receptors in the brain. This can reduce appetite and the reward value of food, curbing cravings and ...